AstraZeneca said Tuesday it's planning to invest $50 billion in expanding its manufacturing and research presence in the U.S. by 2030. The bulk of the funds will go toward building a plan that ...

Johnson & Johnson's robust financial profile enables it to invest heavily in R&D and M&A, driving growth of its innovative medicine and MedTech platforms. Last year, the company spent more than ...

Eli Lilly Investing $27B More In Us Manufacturing AstraZeneca plans to invest $50 billion in the U.S. by 2030, the company announced.

AstraZeneca AZN 3.11% said it plans to invest $50 billion in the U.S. by 2030, marking the latest drugmaker to commit to American manufacturing as looming tariffs threaten to raise costs across ...

The CEO highlighted Johnson & Johnson's plan, which it announced earlier this year, to invest more than $55 billion in the U.S. over the next four years toward manufacturing, research and technology.

AstraZeneca has announced plans to invest $50 billion in the U.S. by 2030 amid concerns over tariffs. The British pharmaceutical company said its investment would fund a new drug manufacturing ...